Evidence map›Paper›PMID 27821775›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Gut microbiota induce IGF-1 and promote bone formation and growth.

Jing Yan, Jeremy W Herzog, Kelly Tsang, Caitlin A Brennan, Maureen A Bower, Wendy S Garrett, Balfour R Sartor, Antonios O Aliprantis, Julia F Charles

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04015999 (Microbiota-directed Complementary Food), which is not on this map. Cited by 450 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
450citing papers in PubMed, 3 pooled it
22.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04015999 phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Microbiota-directed Complementary Food (MDCF) Trial

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2018 to 2021Enrolled124ConditionsMicrobiota, Complementary Food, NutritionArmsMicrobiota Directed Complementary Food (MDCF), Ready to Use Supplementary Food (RUSF)
3 · Its place in the literature

Who cites it

450 citing papers in PubMed, 3 syntheses or guidelines pooled it, 710 citations in OpenAlex.

  1. Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  2. A systematic review and meta-analysis of the effects of probiotics on bone outcomes in rodent models.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Pooled it
  3. Pooled it
  4. Effects of Heat-KilledNutrients · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

390 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jing YanDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
Jeremy W HerzogNational Gnotobiotic Rodent Resource Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Kelly TsangDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
Caitlin A BrennanDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115.
Maureen A BowerNational Gnotobiotic Rodent Resource Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Wendy S GarrettDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115.
Balfour R SartorNational Gnotobiotic Rodent Resource Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Antonios O AliprantisDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-8744-2535
Julia F CharlesDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; JFCHARLES@partners.org.
Brigham and Women's Hospital · USUniversity of North Carolina at Chapel Hill · USBroad Institute · USHarvard University · US

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
National Gnotobiotic Rodent Resource CenterP40OD010995 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ryan B Sartor · 2012 to 2026
$9.7M
Gut microbiota and inflammatory monocytes in colorectal cancerR01CA154426 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI GARRETT, WENDY S. · 2011 to 2025
$5.2M
Myeloid precursors and the microbiome in the osteoimmunology of agingR01AG046257 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI CHARLES, JULIA F · 2013 to 2017
$1.1M
Osteoclast precursors in bone homeostasis and inflammatory arthritisK08AR062590 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CHARLES, JULIA F · 2012 to 2016
$619k
NCI NIH HHS R01 CA154426NIAMS NIH HHS K08 AR062590NIA NIH HHS R01 AG046257NIDDK NIH HHS P30 DK034987NIH HHS P40 OD010995
6 · The paper itself

Abstract

Appreciation of the role of the gut microbiome in regulating vertebrate metabolism has exploded recently. However, the effects of gut microbiota on skeletal growth and homeostasis have only recently begun to be explored. Here, we report that colonization of sexually mature germ-free (GF) mice with conventional specific pathogen-free (SPF) gut microbiota increases both bone formation and resorption, with the net effect of colonization varying with the duration of colonization. Although colonization of adult mice acutely reduces bone mass, in long-term colonized mice, an increase in bone formation and growth plate activity predominates, resulting in equalization of bone mass and increased longitudinal and radial bone growth. Serum levels of insulin-like growth factor 1 (IGF-1), a hormone with known actions on skeletal growth, are substantially increased in response to microbial colonization, with significant increases in liver and adipose tissue IGF-1 production. Antibiotic treatment of conventional mice, in contrast, decreases serum IGF-1 and inhibits bone formation. Supplementation of antibiotic-treated mice with short-chain fatty acids (SCFAs), products of microbial metabolism, restores IGF-1 and bone mass to levels seen in nonantibiotic-treated mice. Thus, SCFA production may be one mechanism by which microbiota increase serum IGF-1. Our study demonstrates that gut microbiota provide a net anabolic stimulus to the skeleton, which is likely mediated by IGF-1. Manipulation of the microbiome or its metabolites may afford opportunities to optimize bone health and growth.

Indexed as

Bone DevelopmentGastrointestinal MicrobiomeAdipose TissueAnimalsBone and BonesFatty Acids, VolatileFemaleInsulin-Like Growth Factor ILiverMaleMiceOsteogenesisSpecific Pathogen-Free OrganismsFatty Acids, Volatileinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IboneIGF-1microbiotaSCFA

Identifiers

PMID27821775
PMCPMC5127374
OpenAlexW2556090133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.